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CBA/N mice have an x-linked immunodeficiency that is mainly expressed by 
poor antibody production to some T-independent antigens, called TI-2 antigens 
(1-4) and to a few T-dependent antigens (5-8).  This functional defect is associ- 
ated with a  failure in development of a  late-appearing B lymphocyte subset (9) 
that can  be defined in  normal animals by distinctive surface antigens such as 
Lyb-3 (10), Lyb-5 (11), and others (12-14).  Because many TI-2 antigens induce 
IgG antibody largely of the IgG3 subclass (15,  16), a normally minor subclass of 
IgG,  and  because  CBA/N  mice  are  deficient  in  IgG3  production  (17),  we 
proposed that the Lyb-3 +, -5  ÷ B cell subpopulation may be responsible for the 
bulk of IgG3 production and that IgG3 subclass response to any antigen would 
be defective in CBA/N (16). This has been confirmed for both T-independent 
and  T-dependent  antigens  (5,  6,  16).  Antibodies  of  other  isotypes  are  less 
regularly influenced by the immunodeficiency (5). 
The mutation in CBA/N mice, called xid,  is linked to the x chromosome (1). 
Because  of x  chromosome  inactivation,  females  heterozygous  for xid  will  be 
mosaics, with some cells expressing the xid-bearing x chromosome, others not. 
Further, the recessive nature of the xid trait results in heterozygous females that 
are phenotypically normal (1).  By examining x  chromosome expression in the 
cells of these animals, it should be possible to determine whether the effect of 
xid on B cell development is direct or indirect. Direct effects, whereby the normal 
counterpart of the xid gene product(s) is expressed within the B cell and permits 
its development, would result in unbalanced x chromosome mosaicism among B 
lymphocytes from xid heterozygous females, because only B cells expressing the 
normal x chromosome could develop. Conversely, indirect effects, where the xid 
gene product(s) is expressed  by non-B cells that subsequently influence B cell 
development or function, would result in balanced mosaicism among B lympho- 
cytes.  Here we examine x  chromosome expression in xid heterozygous female 
mice using alloenzymes of phosphoglycerate kinase- 1 (PGK- 1)1 as x chromosome 
markers. 
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Materials and Methods 
Animals.  AT-10 female mice bearing Pgk-1 a allele were obtained from Dr. V. Chapman 
(Rosweil Park Memorial Institute, Buffalo, NY). Since AT-10 is congenic to C3H/HeHa, 
males with Pgk-1 a were obtained by mating female AT-10 with male C3H/HeHa (Seneca 
Laboratory, West Seneca, NY). These males with Pgk-1 a allele were used to produce the 
experimental animals by mating with female CBA/N (maintained in our facilities from 
original stocks obtained from the National Institutes of Health), CBA/J (animal F), and 
C57BL/10SnJ (animals G, H) (The Jackson Laboratory, Bar Harbor, ME). Animals D, E, 
and Q were produced by mating (AT-10 × C3H/HeHa)F1 females with CBA/N males. 
The selection of x chromosomes for inactivation is not random (18-20). Cattanach et 
al. (18) have found the inactivation to be influenced by an x-linked gene called Xce. Three 
alleles of Xce have been described (20) according to their relative preference in determining 
x chromosome expression: Xce  c (AT-10 mice) is most preferred; Xce  b (C57BL/10SnJ) is 
intermediate; and Xce  ~ (CBA and C3H) is least preferred. 
Preparation  of Tissue and Hematopoietic Cells.  PGK enzyme was extracted from various 
hematopoietic cells  by  lysing them  in  phosphate-buffered saline  (PBS)  containing  1% 
Triton X-100 (Sigma Chemical Co.,  St.  Louis,  MO).  Whole blood lysate was  used as 
erythrocyte lysate. Using petri dishes coated with antibody to mouse IgM (21), splenocytes 
were separated into B ceil-enriched ('~81%  DNL1.9  + [22]) and B cell-depleted (~5% 
surface Ig  +) populations.  The enzyme was  extracted from various tissues by mincing 
samples in  PBS followed by freeze and thaw cycles.  Hybridomas were produced from 
heterozygous females after stimulation with 25 #g of iipopolysaccharide (LPS) (Escherichia 
coti 0128:BI 2; Difco Laboratories, Detroit, MI) intraperitoneally. 5 d later their spleno- 
cytes were hybridized with SP2/0-Agl4 cells as described elsewhere (23). The fused cells 
from each animal were distributed in 5-10 96-well plates.  The supernates of the wells 
were screened for IgG 1 and IgG3 production using solid-phase radioimmunoassay (17). 
Cells from fusions with >12% of wells showing cell growth were cloned in soft agar (24). 
The clones were again tested for IgG 1 and IgG3 production. All the cells were maintained 
in culture medium containing hypoxanthine, aminopterin, and thymidine (HAT) (25) to 
minimize loss of the x chromosome. 
Assay of PGK-1 Activity.  Because the enzyme activities of different tissue extracts were 
variable, tissue extracts were diluted until 10 #1 of the extract gave 0.1-0.15 absorbance 
unit changes per minute at 340  nm when 400 #l of substrate  solution was  used.  The 
substrate solution contained 2 mM ATP,  15 mM  3-phosphoglycerate, 12 mM MgSO4, 
0.7 mM disodium EDTA, 0.34 mM NADH, and 2.2 U/ml of glyceraldehyde-3-phosphate 
dehydrogenase (Sigma Chemical Co.) in 100 mM Tris buffer, pH 7.6 (25). The hybridoma 
cell lysates were obtained by lysing hl  ×  106 cells in  100 #l of 1% Triton X-100 in a 
Tris-citrate buffer (225 mM Tris and 75 mM citrate, pH 7). 
Electrophoresis of tissue extracts was performed on cellulose acetate paper (Gelman 
Sciences, Inc., Ann Arbor, MI) at 20 V/cm for 90 min using a pH 6.9 buffer containing 
15 mM Tris, 5 mM Pipes (piperazine-N, N'-bis(2-ethanesulfonic acid); Sigma Chemical 
Co.), and 2.4 mM citrate. Samples (0.25 ~1) were applied to the membrane using a sample 
applicator (Sepratek-8; Gelman  Sciences,  Inc.). The enzyme activity was  visualized by 
overlaying the cellulose acetate paper with a reagent strip (Gelman Sciences, Inc.) soaked 
with substrate solution that contained 25% sucrose but was otherwise identical to that 
described above. A photographic record was made with Polaroid film (type 667) in a long 
wave UV box (Fotodyne, Inc., New Berlin, WI). The enzyme activity was detected as a 
nonfluorescent spot in the strip. Relative amounts of  enzyme allelic forms were determined 
with this method by estimating the dilutions of the sample at which the enzyme activity 
in each band became undetectable. 
Alternatively, electrophoresis of hybridoma cell lysates was performed in  1% agarose 
(equal mixture of medium and low electroendosmosis agarose [Sigma Chemical Co.]) at 
10 V/cm for 6 h using the pH 7 Tris-citrate buffer over a flat-bed cooling plate (LKB, 
Sweden). The enzyme was located by overlaying the electrophoresis gel with a filter paper 
(Whatman-1; Fisher Scientific Co., St. Louis, MO) impregnated with the substrate solution 
without sucrose. After 15-30 min, the filter paper was dried and photographed as above. 922  xid  INFLUENCE  ON  X  CHROMOSOME  MOSAICISM 
Results 
X Chromosome Expression in Hematopoietic Cells.  Relative expression of the two 
alleles of Pgk among hematopoietic cells was studied.  Fig.  1 shows examples of 
the PGK-1  isoenzyme patterns of cell lysates of splenocytes either enriched for 
(E) or depleted of (D) B cells. The upper and lower bands represent the variant 
PGK- 1A and more common PGK- 1B isoenzymes, respectively. By determining 
the dilutions of the cell lysate at which the enzymatic activity of each isoenzyme 
becomes undetectable, a semiquantitative estimate of the relative expression of 
the enzyme can be made. Thus, cells from two animals heterozygous for Pgk but 
lacking xid (Fig.  1, control) show either equal representation of the enzymes or 
slight preference of the  PGK-1  alloenzyme.  These patterns of mosaicism were 
seen in spleen cell populations depleted of or enriched for B cells as well as in 
thymocytes and  erythrocytes  (Table  I).  In  fact,  the  degree  of x  chromosome 
mosaicism is  largely shared among diverse hematological cell populations (27). 
On the other hand, cells from animals heterozygous for Pgk and for xid (Fig.  1, 
experimental animals and Table  I) show different patterns of PGK expression. 
Although erythrocytes,  thymocytes, and  B-depleted splenocytes resemble each 
other, B-enriched populations of splenocytes are nearly devoid of the isoenzyme 
encoded by the x chromosome bearing the xid gene. This strongly suggests that 
FIGURE  1.  Estimation of isoenzyme activity by serial dilution. Experimental mice are heter- 
ozygous for  xid and  Pgk-1, whereas  the  control  mice are  heterozygous  for Pgk-1 only.  S, 
position standards;  E, splenocyte sample enriched for B cells;  D, splenocyte sample depleted 
of B cells.  Serial dilution is in the direction shown with horizontal arrows. NAHM,  PASLAY,  AND  DAVIE 
TABLE  I 
Pgk-1 Allele Expression in Hematological  Samples 
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Cell types 
Experimental animals  Control animals 
A  B  C  D  E  F  G  H 
Erythrocytes  2  4  3  3  3  2  0.5  1 
Thymocytes  3  3-9  3  3  1  1-3  0.3  1 
Splenocytes  9  9  9  3-9  9  3  1  1 
B cell-depleted  3  3  3  3  3  1-3  0.5  1 
splenocytes 
B cell-enriched  >3  >9  27  >9  >9  1-3  0.5-1  1 
splenocytes 
Numbers represent the ratio of enzyme activity between PGK-1A and PGK-1B isoenzymes. 
B lymphocytes with the xid gene defect do not develop. 
The slight predominance of the Pgk-1 a allele seen in many animals is probably 
the result of the regulation of x  chromosome inactivation by Xce, and uncon- 
nected with xid, because all animals expressing this preference (A-F) are Xcea/ 
Xce  c heterozygotes, while the two with more equal expression (G and H) are Xceb/ 
Xce  c heterozygotes. 
Most studies of animals expressing the xid trait have identified B cells as the 
principal target of the immunodeficiency, but  only a  subpopulation,  approxi- 
mately half of the total B cells, are thought to be involved (2, 4,  10,  11).  The 
very marked changes in isoenzyme expression we find in isolated B cells suggests 
either that most B lymphocytes are affected by xid or that the amount of enzyme 
per cell produced by Pgk-1 ~- and Pgk-lb-bearing cells are different. To distinguish 
these alternatives,  individual B  cells must be examined. However, because of 
limitations in sensitivity of the enzyme assay in which 105-106 cells per determi- 
nation are required, individual B lymphocytes were clonally expanded by somatic 
cell hybridization with myeloma cells. This technique is known to preserve the 
status of the inactive x chromosome (28, 29), unless a stringent selection is used 
(30). 
We chose to compare x chromosome expression in IgG3- and IgGl-secreting 
hybridomas, because the xid trait is known to depress IgG3 production uniformly 
(5,  6,  16,  17),  but has only variable effects on  IgG1  (5,  17).  We obtained 93 
IgG3-producing hyridomas and 43  IgGl-producing hybridomas from nine ani- 
mals;  their  phenotypes are  summarized in  Table  II. Since  the  SP2/O-Agl4 
myeloma cells have a Pgk-1 b allele, a  hybridoma generated from fusion with a 
splenocyte bearing Pgk-1 b allele would express  only one slow-moving enzyme 
band.  This  phenotype is  labeled as  CBA/N  type in  Table  II.  However,  if a 
hybridoma was  formed from a  splenocyte that  expressed a  Pgk-1 a allele,  the 
hybridoma would have both Pgk-1 alleles and show two bands upon electropho- 
resis. These hybridomas are labeled as AT-10 type in Table I I. If an AT-10 type 
hybridoma discards the active splenocyte x chromosome, then phenotypically the 
hybridoma would express only the slow moving PGK-1B enzyme and be indistin- 
guishable from the CBA/N  type.  Even though all the hybridomas were main- 
tained  in  HAT  selection  media  to  minimize this  conversion,  there  may  be 
examples of the splenocyte x chromosome loss. 924  xid  INFLUENCE  ON  X  CHROMOSOME  MOSAICISM 
TABLE II 
Enzyme Phenotypes of  Hybridomas 
Animal 
IgG3-secreting clones  IgG l-secreting clones 
AT- 10 type  CBA/N  CBA/N  type  AT- 10 type  type 
I  13  1  9  0 
J  9  1  8  0 
K  9  1  1  0 
L  13  0  2  0 
M  10  1  0  10 
N  7  2  3  0 
O  11  0  0  3 
P  4  0  2  0 
Q  10  1  5  0 
Total  86  7  30  13 
As  with  splenocyte populations,  the  AT-10  x  chromosome  is  preferentially 
active  among  both  IgG1-  and  IgG3-producing  hybridomas.  ~70%  of IgG1- 
secreting  and  -~93%  of IgG3-secreting  hybrid  cell  lines  express  both  PGK-1 
isoenzymes.  Given  the  possibility  of chromosome  loss,  these  values  may  be 
underestimates.  To rule  out multiple  representation  of the  same  B  cell clone 
among  the  hybridomas,  only  one  clone  was  derived  from  a  single  well  and 
electrophoretic mobilities of the IgG1  hybridoma proteins from animal M were 
shown to be different. However, it is clear that not all B cells express the AT-10 
phenotype, because in two animals  (M and  O) all of the  IgGl-secreting  hybri- 
domas were of the CBA/N phenotype. Interestingly, in these animals, nearly all 
of the IgG3-secreting cells expressed the AT-10 phenotype. These results thus 
suggest that the number of bone marrow stem cells for B cells is small and that 
at least occasionally the stem cells that generate IgG3-secreting cells are different 
from those that generate IgG 1 secretors. 
Isoenzyme Patterns in Tissue.  To determine whether other cell types in addition 
to B lymphocytes expressed the unbalanced x chromosome mosaicism as a result 
ofxid gene expression, a survey was made of various tissues for PGK-1 isoenzyme 
expression in xid heterozygous mice. Extracts of brain, kidney, liver, muscle, and 
peritoneum were examined (Fig. 2). No consistent differences were seen between 
control and  experimental  groups of animals;  most animals  expressed both iso- 
enzymes in similar  amounts although  occasional animals  expressed one or the 
other enzyme dominantly.  Further,  most tissues from an individual animal  had 
the same pattern,  although  striking  exceptions are evident. This is clearly seen 
in  the  brain  of animal  B  as well as in  the  liver  and  peritoneum  of animal  C. 
Further,  all parts of the liver from animal  C had the extreme PGK-1 a predomi- 
nance  (data  not  shown).  These  examples  are  consistent  with  the  notion  that 
various organs arise from limited numbers of precursor cells (31-33). However, 
in this limited survey of tissues no consistent trend in unbalanced X-chromosome 
expression was seen between experiments and control animals. Study of individ- 
ual cell types within  the various tissues is required  to determine  whether only 
certain cell types express unbalanced mosaicism. NAHM,  PASLAY, AND  DAVIE  925 
FIGURE 2.  Electrophoretic  patterns  of PGK-1 isoenzymes from various tissues. Position 
standards are marked with vertical arrows. Source of tissues: B, brain;  K, kidney; L, liver;  M, 
muscle; P, peritoneum; R, erythrocytes. Experimental animals A-E are heterozygous for xid 
and Pgk-1. Control animals F, G, and H are heterozygous for Pgk-1 only. 
Discussion 
The nature of the lesion(s) induced by xid has been studied extensively. Defects 
identified  have  included  Lyb-3,  -5,  and  -7-bearing  B  cells  (10-12),  Ia.W39- 
bearing B  cells and/or  macrophages (13),  as  well as some  (34,  35),  but  not all 
(:36,  37), T  helper cells. These defects produce poor response to many polysac- 
charides (1,3, 6, 16) and some proteins and polypeptides under immune response 
gene control (5), and a  tendency to develop tolerance in vitro more easily than 926  xid  INFLUENCE  ON  X  CHROMOSOME  MOSAICISM 
normal (38).  Because the functions involved depend on several cells, and even 
the development of a class of lymphocyte may depend on other cells (39, 40), it 
is not clear which if any of the defects is the initial lesion and which are secondary. 
Analysis of x  chromosome mosaicism in heterozygous females is a  more direct 
approach to this question. Cell populations directly affected by the xid mutation 
should  not  express  the  xid-bearing  x  chromosome,  whereas  those  indirectly 
affected or unaffected should express this chromosome randomly. 
The preliminary results reported here show clearly that B lymphocytes express 
unbalanced x  chromosome mosaicism.  Other cell populations do not, but this 
may reflect the failure to examine homogeneous subpopulations.  Until this is 
possible, we cannot conclude that B lymphocytes are the only cell type directly 
affected by xid. 
Examination of B cell subpopulations by hybridoma technology showed that 
IgG3-secreting cells nearly always expressed the normal x  chromosome, while 
many IgGl-secreting cells expressed the xid-bearing x chromosome. These data 
support the idea that xid preferentially affects a subset of B lymphocytes (10,  11) 
that is associated with IgG3 production (16,  17).  Whether the population  not 
associated with IgG3 is unaffected by xid cannot be stated with assurance because 
only small numbers of cells have been examined. It does seem certain, however, 
that B  lymphocyte subpopulations  may express xid-bearing  x  chromosomes to 
different degrees. 
Other examples of unbalanced x chromosome mosaicism exist. Lesch-Nyhan 
syndrome in man is caused by a deficiency in the x-linked enzyme, hypoxanthine- 
guanine phosphoribosyl  transferase  (41).  Carriers  of this  recessive trait  have 
erythrocytes exclusively derived from stem cells expressing the normal x chro- 
mosome; individual fibroblasts may express either (42). Similarly, carriers of the 
trait for Wiskott-Aldrich syndrome, an x-linked recessive disease involving im- 
munodeficiency and thrombocytopenia, have unbalanced mosaicism of glucose- 
6-phosphate dehydrogenase (G6PD, an x-linked enzyme) among T  lymphocytes 
and platelets particularly, and less  marked effects among other hematopoietic 
cell types (43, 44). 
Unbalanced mosaicism can occur normally because the bulk of many organs 
or cell subpopulations are often derived from small numbers of precursor cells. 
For instance, study of G6PD  mosaicism suggests that human erythrocytes are 
derived from 8-19  precursor cells (31).  Also mosaicism in skin showed mouse 
melanocytes are derived from  34  cells  (33).  Further,  because x  chromosome 
inactivation  occurs  early  in  embryogenesis and  is  permanent  (45-47),  topo- 
graphic mosaicism is a normal feature in heterozygous females (18). Thus, small 
samples of organs or cell populations such as a patch of skin are unrepresentative 
of the whole, and may express unbalanced mosaicism. Our results with several 
organs (brain, peritoneum, and liver, Fig.  2) are consistent with either mecha- 
nism.  Nevertheless finding  10  randomly selected but  different CBA/N  IgG1 
hybridomas from one animal (Table II) supports the idea of limited precursor 
cells. Also the imbalance throughout the entire liver in animal C clearly supports 
the view that hepatocyte precursors are few. However, unlike the situations with 
the xid-mediated  immunodeficiency, Wiscot't-Aidrich syndrome and Lesch-Ny- 
ban syndrome, this imbalance of normal mosaicism arises due to random expres- NAHM,  PASLAY,  AND  DAVIE  927 
sion of x chromosomes. 
Having established  that  B  lymphocytes are  most likely a  direct  target of xid 
gene effects, is it possible to determine when in hemopoietic development that 
xid acts? We have found no gross effect of xid in T  cells. The fact that marrow 
grafting from normal to nonirradiated  CBA/N establishes B cell but not T  cell 
chimerism (48) is also consistent with the notion that B cell precursors, but not 
T  cell precursors, are defective; thus, common lymphoid stem cells are probably 
not affected.  Kincade  and  co-workers (49,  50)  have  determined  that  CBA/N 
mice appear to develop pre-B cells with cytoplasmic # and the  14.8 determinant 
(known to be expressed on B cell precursors) at the appropriate  time in devel- 
opment (49),  but that  cells which give rise to B cells capable of growth in soft 
agar (clonable B cells) fail to develop (50). Cionable B cells appear simultaneously 
with surface Ig-bearing B cells at "~ 16-17 d  of gestation. Thus, xid operates at 
least at an early stage of B cell development. Another x-linked immunodeficiency 
in  DBA/2Ha mice has been localized  to B  lymphocytes. This gene appears  to 
encode for a B cell receptor for T  cell replacing factor (51). Thus, x-linked genes 
are involved in early and later stages of B cell differentiation. 
These  results  are  consistent  with several  models of B  cell  development,  xid 
may block the  development  of more  mature  B  cells such as  Lyb-5  + cells and 
clonable B cells from Lyb-5- cells. Alternatively, there may be several pathways 
of B  cell  development  that  diverge early and  give rise to different functional 
subsets. The development of subsets responsive to TI-2 antigens  is sensitive to 
xid.  These  models  would suggest  that  the  subset of B  cells which  develop in 
CBA/N animals would be normal.  There is evidence, however, that the Lyb-5- 
B cells of CBA/N mice may not be equivalent to Lyb-5- B cells of normal animals. 
DeFranco and colleagues (52) noted that CBA/N B cells respond differently than 
normal  cells  to  anti-~  stimulation.  Although  both  defective and  nondefective 
cells increase in size, defective cells fail to proliferate. Thus, it may be that even 
the B cells which develop in CBA/N mice may not be normal.  Our results with 
x  chromosome expression are consistent with this  notion,  although  we do not 
wish to draw too fine a distinction because our data are limited.  B cells from xid 
heterozygous females are more unbalanced  in  their  x  chromosome expression 
that would be expected if only a subpopulation were affected. It may be that xid- 
expressing B cells are at a proliferative disadvantage when compared with normal 
cells and  that  heterozygotes reflect this  selection.  Considerably more data are 
required to be confident about the extent of skewed expression of x chromosomes 
in heterozygotes; it is clear that it is substantial. 
Finally, attention should be called to the utility of x-linked isoenzyme expres- 
sion in the dissection of x-linked diseases, particularly immunodeficiencies.  The 
x-chromosome plays an important  role in the normal  immune system. At least 
five immunodeficiency diseases in humans (53) and two in mice involve x-linked 
genes.  The determination  of the pattern  of x  chromosome expression in these 
diseases should be particularly informative. 
Summary 
The immunodeficiency in CBA/N mice is reflected by abnormal development 
of a subset of B lymphocytes. However, it is not clear how xid, the mutant gene 928  xid  INFLUENCE  ON  X  CHROMOSOME  MOSAICISM 
in  CBA/N  mice,  affects the  development of this  subset.  Specifically, it  is  not 
known if the xid gene influences the development of the B cell subset directly or 
indirectly by providing the  improper developmental milieu through effects on 
other cells.  We  investigated  this  question  using  female mice heterozygous for 
two  x  chromosomal  genes,  xid  and  Pgk-1  (phosphoglycerate  kinase-1).  Since 
females are mosaic because of x chromosome inactivation, their lymphocytes can 
be studied for the choice of the x chromosome, using the two PGK-1 isoenzymes 
as the cytological marker. We find that B lymphocytes in the spleen prefer the x 
chromosome without xid while the remaining splenocytes and  cells from other 
tissues  do  not.  This  suggests  that  xid  affects  B  lymphocytes directly and  not 
through  their  developmental  milieu.  Furthermore,  our  data  suggest  that  the 
precursors for IgG1- and IgG3-producing cells may be both few and different. 
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